S&P 500   3,940.48 (-0.02%)
DOW   33,653.20 (+0.17%)
QQQ   279.64 (-0.72%)
AAPL   140.83 (-1.46%)
MSFT   243.99 (-0.46%)
META   113.21 (-0.80%)
GOOGL   94.81 (-2.24%)
AMZN   87.86 (-0.44%)
TSLA   172.99 (-3.80%)
NVDA   159.00 (-0.54%)
NIO   12.53 (-5.36%)
BABA   88.74 (-2.96%)
AMD   70.45 (+0.26%)
T   19.33 (+0.83%)
MU   53.33 (-0.65%)
CGC   3.31 (-8.31%)
F   13.26 (-0.15%)
GE   85.20 (-0.09%)
DIS   92.08 (-0.23%)
AMC   6.36 (-5.78%)
PYPL   73.84 (+2.23%)
PFE   50.40 (+1.39%)
NFLX   305.51 (-0.02%)
S&P 500   3,940.48 (-0.02%)
DOW   33,653.20 (+0.17%)
QQQ   279.64 (-0.72%)
AAPL   140.83 (-1.46%)
MSFT   243.99 (-0.46%)
META   113.21 (-0.80%)
GOOGL   94.81 (-2.24%)
AMZN   87.86 (-0.44%)
TSLA   172.99 (-3.80%)
NVDA   159.00 (-0.54%)
NIO   12.53 (-5.36%)
BABA   88.74 (-2.96%)
AMD   70.45 (+0.26%)
T   19.33 (+0.83%)
MU   53.33 (-0.65%)
CGC   3.31 (-8.31%)
F   13.26 (-0.15%)
GE   85.20 (-0.09%)
DIS   92.08 (-0.23%)
AMC   6.36 (-5.78%)
PYPL   73.84 (+2.23%)
PFE   50.40 (+1.39%)
NFLX   305.51 (-0.02%)
S&P 500   3,940.48 (-0.02%)
DOW   33,653.20 (+0.17%)
QQQ   279.64 (-0.72%)
AAPL   140.83 (-1.46%)
MSFT   243.99 (-0.46%)
META   113.21 (-0.80%)
GOOGL   94.81 (-2.24%)
AMZN   87.86 (-0.44%)
TSLA   172.99 (-3.80%)
NVDA   159.00 (-0.54%)
NIO   12.53 (-5.36%)
BABA   88.74 (-2.96%)
AMD   70.45 (+0.26%)
T   19.33 (+0.83%)
MU   53.33 (-0.65%)
CGC   3.31 (-8.31%)
F   13.26 (-0.15%)
GE   85.20 (-0.09%)
DIS   92.08 (-0.23%)
AMC   6.36 (-5.78%)
PYPL   73.84 (+2.23%)
PFE   50.40 (+1.39%)
NFLX   305.51 (-0.02%)
S&P 500   3,940.48 (-0.02%)
DOW   33,653.20 (+0.17%)
QQQ   279.64 (-0.72%)
AAPL   140.83 (-1.46%)
MSFT   243.99 (-0.46%)
META   113.21 (-0.80%)
GOOGL   94.81 (-2.24%)
AMZN   87.86 (-0.44%)
TSLA   172.99 (-3.80%)
NVDA   159.00 (-0.54%)
NIO   12.53 (-5.36%)
BABA   88.74 (-2.96%)
AMD   70.45 (+0.26%)
T   19.33 (+0.83%)
MU   53.33 (-0.65%)
CGC   3.31 (-8.31%)
F   13.26 (-0.15%)
GE   85.20 (-0.09%)
DIS   92.08 (-0.23%)
AMC   6.36 (-5.78%)
PYPL   73.84 (+2.23%)
PFE   50.40 (+1.39%)
NFLX   305.51 (-0.02%)
NASDAQ:AEMD

Aethlon Medical - AEMD Stock Forecast, Price & News

$0.40
-0.01 (-1.63%)
(As of 12/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.40
$0.41
50-Day Range
$0.40
$0.67
52-Week Range
$0.39
$2.46
Volume
83,715 shs
Average Volume
267,130 shs
Market Capitalization
$6.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00

Aethlon Medical MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
901.3% Upside
$4.00 Price Target
Short Interest
Healthy
1.83% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.33mentions of Aethlon Medical in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.74 out of 5 stars

AEMD stock logo

About Aethlon Medical (NASDAQ:AEMD) Stock

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

Receive AEMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter.

AEMD Stock News Headlines

Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Update
Aethlon Medical (NASDAQ:AEMD) Now Covered by StockNews.com
Preview: Aethlon Medical's Earnings
AEMD Aethlon Medical, Inc.
Aethlon Medical, Inc. (AEMD)
Aethlon Medical Q4 2022 Earnings Preview
Earnings Outlook For Aethlon Medical
/C O R R E C T I O N -- Aethlon Medical, Inc./
See More Headlines
Receive AEMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter.

AEMD Company Calendar

Last Earnings
11/09/2021
Today
12/07/2022
Next Earnings (Estimated)
2/13/2023
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AEMD
Fax
N/A
Employees
10
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.00
High Stock Price Forecast
$4.00
Low Stock Price Forecast
$4.00
Forecasted Upside/Downside
+901.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-10,420,000.00
Net Margins
-3,542.86%
Pretax Margin
-43,423.33%

Debt

Sales & Book Value

Annual Sales
$290,000.00
Book Value
$1.10 per share

Miscellaneous

Free Float
16,106,000
Market Cap
$6.65 million
Optionable
Not Optionable
Beta
0.84

Key Executives

  • Dr. Charles J. Fisher Jr. (Age 75)
    M.D., CEO, Director & Member of Extracorporeal Therapy Advisory Board
    Comp: $866.25k
  • Mr. Steven P. Larosa M.D. (Age 55)
    Chief Medical Officer & Acting Chief Scientific Officer
    Comp: $655.34k
  • Mr. Guy F. Cipriani BS (Eng.) (Age 52)
    MBA, Sr. VP, Chief Bus. Officer & Director
    Comp: $635.61k
  • Mr. James B. Frakes M.B.A. (Age 65)
    CFO, Sr. VP of Fin. & Sec.
  • Mr. Sunil Sawhney
    Head of Clinical Studies
  • Dr. Richard H. Tullis Ph.D. (Age 77)
    Consultant













AEMD Stock - Frequently Asked Questions

Should I buy or sell Aethlon Medical stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aethlon Medical in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AEMD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AEMD, but not buy additional shares or sell existing shares.
View AEMD analyst ratings
or view top-rated stocks.

What is Aethlon Medical's stock price forecast for 2023?

1 Wall Street research analysts have issued 1 year price targets for Aethlon Medical's shares. Their AEMD share price forecasts range from $4.00 to $4.00. On average, they expect the company's stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 901.3% from the stock's current price.
View analysts price targets for AEMD
or view top-rated stocks among Wall Street analysts.

How have AEMD shares performed in 2022?

Aethlon Medical's stock was trading at $1.86 at the beginning of 2022. Since then, AEMD shares have decreased by 78.5% and is now trading at $0.3995.
View the best growth stocks for 2022 here
.

Are investors shorting Aethlon Medical?

Aethlon Medical saw a increase in short interest in November. As of November 15th, there was short interest totaling 304,300 shares, an increase of 19.2% from the October 31st total of 255,300 shares. Based on an average trading volume of 270,500 shares, the days-to-cover ratio is presently 1.1 days.
View Aethlon Medical's Short Interest
.

When is Aethlon Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 13th 2023.
View our AEMD earnings forecast
.

How were Aethlon Medical's earnings last quarter?

Aethlon Medical, Inc. (NASDAQ:AEMD) posted its quarterly earnings results on Tuesday, November, 9th. The medical equipment provider reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.02. The medical equipment provider had revenue of $0.13 million for the quarter, compared to analyst estimates of $0.21 million. Aethlon Medical had a negative trailing twelve-month return on equity of 72.02% and a negative net margin of 3,542.86%. During the same quarter in the prior year, the company posted ($0.15) EPS.

What other stocks do shareholders of Aethlon Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Amarin (AMRN), Nokia Oyj (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), CRISPR Therapeutics (CRSP), Novavax (NVAX), OrganiGram (OGI), AT&T (T) and Aurora Cannabis (ACB).

What is Aethlon Medical's stock symbol?

Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."

Who are Aethlon Medical's major shareholders?

Aethlon Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (6.33%), Citadel Advisors LLC (0.74%), Renaissance Technologies LLC (0.37%), Two Sigma Investments LP (0.34%), Buckingham Strategic Partners (0.30%) and Simplex Trading LLC (0.00%).
View institutional ownership trends
.

How do I buy shares of Aethlon Medical?

Shares of AEMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aethlon Medical's stock price today?

One share of AEMD stock can currently be purchased for approximately $0.40.

How much money does Aethlon Medical make?

Aethlon Medical (NASDAQ:AEMD) has a market capitalization of $6.65 million and generates $290,000.00 in revenue each year. The medical equipment provider earns $-10,420,000.00 in net income (profit) each year or ($0.78) on an earnings per share basis.

How can I contact Aethlon Medical?

Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The official website for the company is www.aethlonmedical.com. The medical equipment provider can be reached via phone at (858) 459-7800 or via email at susan@sanoonan.com.

This page (NASDAQ:AEMD) was last updated on 12/7/2022 by MarketBeat.com Staff